Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Noteableon Jun 15, 2024 6:39pm
75 Views
Post# 36090788

RE:RE:RE:RE:RE:RE:RE:RE:Multiple thoughts.

RE:RE:RE:RE:RE:RE:RE:RE:Multiple thoughts.
Russian oligarchs, Putin, dirty money, US real estate, and Russian funded Trump SuperPacs


"The dominant destination of anonymous investment is real estate, which has both great capacity and desired secrecy. Every year, more than $100 billion of foreign funds flow into US real estate, more than half of it in cash. The investigative journalist Oliver Bullough found that “almost one-third of top-end property purchases in America’s biggest cities are suspect, according to the Financial Crimes Enforcement Network, the body at the Treasury Department.”

"Dirty Russian investment in real estate appears to abound in New York and Florida.

One Reuters investigative report found that “at least 703—or about one-third—of the owners of the 2044 units in the seven Trump buildings [in Sunny Beach Isles in Florida] are limited liability companies, or LLCs, which have the ability to hide the identity of a property’s true owner. And the nationality of many buyers could not be determined.” But the “zip code that includes the Sunny Isles buildings has an estimated 1,200 Russian-born residents . . . U.S. Census data show.”

The project generated $2 billion in initial sales, of which at least sixty-three individuals with Russian passports or addresses had bought at least $98.4 million worth of property, while the more dubious Russians are to be found in the LLCs.

The situation is similar in the United Kingdom. James Nickerson of the New Statesman cited the assessment that anonymous offshore companies own thirty-six thousand properties in London at an estimated value of $156 billion. Russians own a large share of this real estate. In May 2016, David Cameron lamented that ninety-nine thousand buildings in the United Kingdom had anonymous owners. A third major entry point for tainted funds into the United States is law firms. The legal excuse is attorney-client privilege, which is supposed to keep communication between an attorney and his or her client secret, but the United States has extended this secrecy to unlimited money flows. "
<< Previous
Bullboard Posts
Next >>